February 26, 2026 at 12:41PM
US FDA to offer bonuses to staff for faster drug reviews, Bloomberg News reports
The U.S. Food and Drug Administration plans to award quarterly bonuses to scientific staff who complete drug reviews more quickly, according to Bloomberg News citing an FDA official familiar with the matter.
The move aims to accelerate drug approvals by incentivizing faster assessment timelines within the agency.
Details on the bonus amounts or eligibility criteria were not disclosed.